HomeNewsIndiaKarnataka COVID-19 panel against reopening schools in December
Trending Topics

Karnataka COVID-19 panel against reopening schools in December

It was important to consolidate gains made after great efforts in the last eight months to contain the disease in the state, the panel said, pointing to the spike or resurgence of cases in Delhi, Haryana, Gujarat, Rajasthan and others.

November 23, 2020 / 14:56 IST
Story continues below Advertisement
Representative image
Representative image

The Technical Advisory Committee for COVID-19 in Karnataka has recommended to the state government not to reopen schools in December ahead of Chief Minister B S Yediyurappa's a key meeting on Monday to take a call on the matter.

"After extensive deliberations it was unanimously resolved not to reopen the schools in December," proceedings of the COVID-19 52nd Technical Advisory Committee (TAC) meeting held on Sunday said.

Story continues below Advertisement

The COVID-19 scenario shall be reviewed in the last week of December to consider reopening of schools at an appropriate time subsequently, it said, adding that this recommendation was for the consideration of the government in the larger public interest of the state.

The schools have remained closed since March when the national lockdown was first enforced to combat COVID-19.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show